Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia - PubMed (original) (raw)
Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia
Salah Mohamed El Sayed et al. Med Hypotheses. 2014 Aug.
Erratum in
- Med Hypotheses. 2015 Aug;85(2):239
Abstract
Iron overload is a big challenge when treating thalassemia (TM), hemochromatosis and sideroblastic anemia. It persists even after cure of TM with bone marrow transplantation. Iron overload results from increased iron absorption and repeated blood transfusions causing increased iron in plasma and interstitial fluids. Iron deposition in tissues e.g. heart, liver, endocrine glands and others leads to tissue damage and organ dysfunction. Iron chelation therapy and phlebotomy for iron overload have treatment difficulties, side effects and contraindications. As mean iron level in skin of TM patients increases by more than 200%, percutaneous iron excretion may be beneficial. Wet cupping therapy (WCT) is a simple, safe and economic treatment. WCT is a familiar treatment modality in some European countries and in Chinese hospitals in treating different diseases. WCT was reported to clear both blood plasma and interstitial spaces from causative pathological substances (CPS). Standard WCT method is Al-hijamah (cupping, puncturing and cupping, CPC) method of WCT that was reported to clear blood and interstitial fluids better than the traditional WCT (puncturing and cupping method, PC method of WCT). In other word, traditional WCT may be described as scarification and suction method (double S technique), while Al-hijamah may be described as suction, scarification and suction method (triple S technique). Al-hijamah is a more comprehensive treatment modality that includes all steps and therapeutic benefits of traditional dry cupping therapy and WCT altogether according to the evidence-based Taibah mechanism (Taibah theory). During the first cupping step of Al-hijamah, a fluid mixture is collected inside skin uplifting due to the effect of negative pressure inside sucking cups. This fluid mixture contains collected interstitial fluids with CPS (iron, ferritin and hemolyzed RBCs in thalassemia), filtered fluids (from blood capillaries) with iron and hemolyzed blood cells (hemolyzed RBCs, WBCs and platelets). That fluid mixture does not contain intact blood cells (having diameters in microns) that are too big to pass through pores of skin capillaries (6-12nm in diameter) and cannot be filtered. Puncturing skin upliftings and applying second cupping step excrete collected fluids. Skin scarifications (shartat mihjam in Arabic) should be small, superficial (0.1mm in depth), short (1-2mm in length), multiple, evenly distributed and confined to skin upliftings. Sucking pressure inside cups (-150 to -420mmHg) applied to skin is transmitted to around skin capillaries to be added to capillary hydrostatic pressure (-33mmHg at arterial end of capillaries and -13mmHg at venous end of capillaries) against capillary osmotic pressure (+20mmHg). This creates a pressure gradient and a traction force across skin and capillaries and increases filtration at arterial end of capillaries at net pressure of -163 to -433mmHg and at venous end of capillaries at net pressure of -143 to -413mmHg resulting in clearance of blood from CPS (iron, ferritin and hemolyzed blood cells). Net filtration pressure at renal glomeruli is 10mmHg i.e. Al-hijamah exerts a more pressure-dependent filtration than renal glomeruli. Al-hijamah may benefit patients through inducing negative iron balance. Interestingly, Al-hijamah was reported to decrease serum ferritin significantly (by about 22%) in healthy subjects while excessive traditional WCT was reported to cause iron deficiency anemia. Al-hijamah is a highly recommended treatment in prophetic medicine. In conclusion, Al-hijamah may be a promising adjuvant treatment for iron overload in TM, hemochromatosis and sideroblastic anemia.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
- Al-hijamah (the triple S treatment of prophetic medicine) significantly increases CD4/CD8 ratio in thalassemic patients via increasing TAC/MDA ratio: a clinical trial.
El-Shanshory M, Hablas NM, El-Tahlawi R, Awny S, Aboonq MS, Al Jaouni SK, Abdel-Latif TM, Abdel-Gawad AR, Okashah AM, Fakhreldin AR, Baghdadi H, El-Allaf H, Shebel Y, El-Sawy SA, Albeihany A, Mahmoud HS, Sayed AA, Abu-Elnaga MA, Nabo MMH, El-Dardear A, Abdel-Rahman IM, El Sayed SM, Mahmoud AA. El-Shanshory M, et al. Am J Blood Res. 2022 Aug 15;12(4):125-135. eCollection 2022. Am J Blood Res. 2022. PMID: 36147606 Free PMC article. - Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes.
El Sayed SM, Baghdadi H, Abou-Taleb A, Mahmoud HS, Maria RA, Ahmed NS, Helmy Nabo MM. El Sayed SM, et al. J Blood Med. 2014 Oct 30;5:219-37. doi: 10.2147/JBM.S65042. eCollection 2014. J Blood Med. 2014. PMID: 25382989 Free PMC article. Review. - Ameliorating Role Exerted by Al-Hijamah in Autoimmune Diseases: Effect on Serum Autoantibodies and Inflammatory Mediators.
Baghdadi H, Abdel-Aziz N, Ahmed NS, Mahmoud HS, Barghash A, Nasrat A, Nabo MM, El Sayed SM. Baghdadi H, et al. Int J Health Sci (Qassim). 2015 Apr;9(2):207-32. Int J Health Sci (Qassim). 2015. PMID: 26309442 Free PMC article. Review. - Al-hijamah (wet cupping therapy of prophetic medicine) significantly and safely reduces iron overload and oxidative stress in thalassemic children: a novel pilot study.
El-Shanshory M, Hablas NM, Shebl Y, Fakhreldin AR, Attia M, Almaramhy HH, Baghdadi H, Ayat M, Albeihany A, El-Dardear A, Ibrahim HA, Mahmoud HS, Nabo MMH, El Sayed SM. El-Shanshory M, et al. J Blood Med. 2018 Dec 14;9:241-251. doi: 10.2147/JBM.S170523. eCollection 2018. J Blood Med. 2018. PMID: 30588142 Free PMC article.
Cited by
- Therapeutic benefits of prophetic medicine remedies in treating hematological diseases (A review article).
Mogharbel GH, Badawi AS, Zaman AY, Abd Elmoniem MM, Abdel-Rahman IM, Alenazi ME, Shah FA, Aly MA, Imam SN, Alenazi NE, El Sayed SM. Mogharbel GH, et al. Am J Blood Res. 2023 Aug 15;13(4):130-142. eCollection 2023. Am J Blood Res. 2023. PMID: 37736537 Free PMC article. Review. - Suggested Integrative Approach for Hand Abscess with Cupping Therapy: a case study.
Hussein EAF, Negm SHI, Shaikh TI, Saleh AH. Hussein EAF, et al. J Pharmacopuncture. 2023 Mar 31;26(1):94-98. doi: 10.3831/KPI.2023.26.1.94. J Pharmacopuncture. 2023. PMID: 37007287 Free PMC article. - Biochemical Origin of the Warburg Effect in Light of 15 Years of Research Experience: A Novel Evidence-Based View (An Expert Opinion Article).
El Sayed SM. El Sayed SM. Onco Targets Ther. 2023 Mar 5;16:143-155. doi: 10.2147/OTT.S397593. eCollection 2023. Onco Targets Ther. 2023. PMID: 36911533 Free PMC article. - Al-hijamah (the triple S treatment of prophetic medicine) significantly increases CD4/CD8 ratio in thalassemic patients via increasing TAC/MDA ratio: a clinical trial.
El-Shanshory M, Hablas NM, El-Tahlawi R, Awny S, Aboonq MS, Al Jaouni SK, Abdel-Latif TM, Abdel-Gawad AR, Okashah AM, Fakhreldin AR, Baghdadi H, El-Allaf H, Shebel Y, El-Sawy SA, Albeihany A, Mahmoud HS, Sayed AA, Abu-Elnaga MA, Nabo MMH, El-Dardear A, Abdel-Rahman IM, El Sayed SM, Mahmoud AA. El-Shanshory M, et al. Am J Blood Res. 2022 Aug 15;12(4):125-135. eCollection 2022. Am J Blood Res. 2022. PMID: 36147606 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials